Elaine T Lam Selected Research

Biliary Tract Neoplasms (Biliary Tract Cancer)

1/2021

A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elaine T Lam Research Topics

Disease

18	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 09/2014
17	Neoplasms (Cancer) 01/2022 - 12/2008
9	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2012
6	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2015
4	Anemia 01/2022 - 11/2010
4	Fatigue 01/2020 - 11/2010
3	Disease Progression 01/2022 - 02/2012
2	Kidney Neoplasms (Kidney Cancer) 01/2022 - 11/2019
2	Brain Neoplasms (Brain Tumor) 12/2021 - 01/2021
2	Vomiting 09/2020 - 11/2010
2	Hypersensitivity (Allergy) 09/2020 - 03/2020
2	Nausea 09/2020 - 11/2010
2	Exanthema (Rash) 05/2020 - 11/2010
1	Hypercalcemia (Milk Alkali Syndrome) 01/2022
1	Teratoma (Teratoid Tumor) 10/2021
1	Nonseminomatous germ cell tumor 10/2021
1	Residual Neoplasm 10/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021
1	Spinal Cord Compression 03/2020
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 03/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Edema (Dropsy) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Hypothyroidism 12/2016
1	Circulating Neoplastic Cells 05/2015
1	Carcinoma (Carcinomatosis) 02/2015
1	Thrombocytopenia (Thrombopenia) 11/2010
1	Neutropenia 11/2010

Drug/Important Bio-Agent (IBA)

5	Sunitinib (Sutent)FDA Link 01/2022 - 12/2016
5	Tyrosine Kinase InhibitorsIBA 10/2021 - 09/2014
4	AndrogensIBA 01/2021 - 12/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2015
3	Axitinib (AG 013736)IBA 01/2022 - 02/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
3	Docetaxel (Taxotere)FDA Link 01/2022 - 11/2010
3	NivolumabIBA 01/2021 - 05/2020
3	Pharmaceutical PreparationsIBA 10/2019 - 06/2015
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 12/2018
2	avelumabIBA 01/2022 - 01/2021
2	sapanisertibIBA 01/2022 - 01/2020
2	pembrolizumabIBA 01/2022 - 01/2021
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 01/2020
2	cabozantinibIBA 12/2021 - 01/2019
2	IpilimumabIBA 01/2021 - 05/2020
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2020
2	atezolizumabIBA 01/2020 - 01/2020
2	Hormones (Hormone)IBA 12/2015 - 05/2015
2	Celecoxib (Celebrex)FDA Link 05/2012 - 12/2008
1	Biological ProductsIBA 01/2022
1	MTOR InhibitorsIBA 01/2022
1	CalciumIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	enzalutamideIBA 01/2021
1	abirateroneIBA 01/2021
1	fosaprepitant FDA Link 09/2020
1	IronIBA 05/2020
1	CationsIBA 05/2020
1	Dapsone FDA Link 03/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2020
1	SteroidsIBA 03/2020
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 03/2020
1	Aurora Kinase AIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	MLN 8237IBA 01/2020
1	PhytochemicalsIBA 12/2018
1	AntioxidantsIBA 12/2018
1	PT2385IBA 01/2018
1	TWEAK ReceptorIBA 01/2018
1	EnzymesIBA 01/2018
1	enavatuzumabIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Angiopoietin-1IBA 06/2015
1	trebananibIBA 06/2015
1	Angiopoietin-2IBA 06/2015
1	cixutumumabIBA 05/2015
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2015
1	bicalutamide (Casodex)FDA LinkGeneric 05/2015
1	pazopanib FDA Link 02/2015
1	Interleukin-2 (IL2)IBA 09/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2014
1	ON 01910IBA 03/2014
1	CateninsIBA 03/2014
1	Polo-Like Kinase 1IBA 03/2014
1	Epothilones (Epothilone)IBA 02/2012
1	KOS-1584IBA 02/2012
1	Suramin (Suramin Sodium)IBA 11/2010

Therapy/Procedure

17	Therapeutics 01/2022 - 11/2010
6	Drug Therapy (Chemotherapy) 10/2021 - 11/2010
4	Radiotherapy 03/2020 - 12/2013
3	Castration 01/2022 - 05/2015
2	Immunotherapy 01/2022 - 05/2020
1	Oral Administration 01/2022
1	Proton Therapy 01/2017
1	Nephrectomy 01/2016
1	Aftercare (After-Treatment) 11/2015
1	Prostatectomy (Retropubic Prostatectomy) 12/2013